Skip to main content
Clinical Trials/NCT02276469
NCT02276469
Completed
N/A

Randomized Controlled Trial of Peer to Peer Support for People With Severe Mental Disorders: Schizophrenia, Affective Disorders and Personality Disorders in Comparison to Standard Care

Universitätsklinikum Hamburg-Eppendorf0 sites200 target enrollmentJuly 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Psychosis
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Enrollment
200
Primary Endpoint
Change from Baseline in Self-Efficacy at 6 month
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine wether peer support is effective for the treatment of people with severe mental illness.

Detailed Description

A randomized controlled multi center trial is conducted, where patients receive usual care in the control group and usual care with additional peer support for 6 month in the intervention group. Psychosocial outcome criteria are collected pre intervention, after 6 month intervention and at one year follow up. Days till hospitalization and days spent in hospital are collected for one year before recruitment and one year after recruitment.

Registry
clinicaltrials.gov
Start Date
July 2011
End Date
December 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. Thomas Bock

Prof.Dr.

Universitätsklinikum Hamburg-Eppendorf

Eligibility Criteria

Inclusion Criteria

  • clinical diagnosis of schizophrenia, unipolar depression, bipolar disorder, personality disorder

Exclusion Criteria

  • primary clinical diagnosis of addiction

Outcomes

Primary Outcomes

Change from Baseline in Self-Efficacy at 6 month

Time Frame: 1. Baseline; 6 month follow up (post intervention); twelve month follow

General Self-Efficacy Scale; Self report Questionnaire; 10 Items

Secondary Outcomes

  • Service satisfaction after six month of intervention(After six month intervention)
  • Change from Baseline in Psychosocial functioning at 6 and 12 month(1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow)
  • Change from Baseline in Quality of life at 6 and 12 month(1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow)
  • Change from Baseline in Illness management, Coping at 6 and 12 month(1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow)
  • Hospitalization in days of in-patient care(one year before, until one year past intervention)
  • Change from Baseline in Severity of illness at 6 and 12 month(1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow)
  • Days to hospitalization(Baseline until 12 month follow up)

Similar Trials